01:58 PM EDT, 05/10/2024 (MT Newswires) -- Guardant Health ( GH ) shares were up 9% in recent Friday trading, a day after the company reported narrower loss and higher revenue.

The company reported a Q1 adjusted loss late Thursday of $0.46 per diluted share, narrowing from a loss of $1.06 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.73 per share.

Revenue for the quarter ended March 31 was $168.5 million, up from $128.7 million a year earlier. Analysts surveyed by Capital IQ expected $157.9 million.

For the full year 2024, the company raised its revenue, excluding screening, guidance to $675 million to $685 million, compared with $655 million to $670 million, previously. Analysts expect revenue of $677.9 million.

Price: 21.18, Change: +1.74, Percent Change: +8.95